<DOC>
	<DOC>NCT00775892</DOC>
	<brief_summary>A multi-center single-arm clinical trial is being conducted to evaluate SeriACL device safety and performance during total anterior cruciate ligament (ACL) reconstruction.</brief_summary>
	<brief_title>SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair</brief_title>
	<detailed_description />
	<criteria>Major Complete rupture of the ACL Passive flexion &gt;= 120° and passive extension = contralateral knee MCL grade 2 or less Preinjury Tegner score &gt;= 4 Informed Consent Major Prior ACL reconstruction. Severe pain, swelling, or redness Complete PCL tear Complex menisci tears Contralateral knee ligament injury OA &gt; Grade II</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>ACL</keyword>
	<keyword>Ligament</keyword>
</DOC>